NPS Pharmaceuticals, Inc. to Report GATTEX(TM) Data at ESPEN, ACG, UEGW Congresses

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals (Nasdaq: NPSP) today reported that data from clinical studies of GATTEX™ (teduglutide) in intestinal failure associated with short bowel syndrome will be presented at upcoming medical meetings.